New China Telmisartan Market Investigation Research Report, 2018-2022 – Industrial IT

0

Global The Chinese market of Telmisartan The growth, share, size, trends and forecast report provides an in-depth analysis of the China telmisartan market including a detailed description of the market size and growth, value, key opportunities on the Chinese telmisartan market and describes the factors which are and will be driving the growth of the industry taking into account the previous growth models with the forecast period 2022

Get a sample PDF of the report –https://www.marketreportsworld.com/enquiry/request-sample/12855104

Desreportption

At the end of 2017, there were around 330 million hypertensive patients in China, in other words, one in three adults in China had hypertension. The incidence of hypertension in China fell from 5.1% in 1959 to 37.2% in 2017.

Angiotensin II receptor blockers (angiotensin receptor blockers, ARBs) are antihypertensive drugs that have experienced rapid growth since their onset in the 1990s. As an important ARA administered orally once a week day to treat essential hypertension,

Telmisartan was discovered by Boehringer Ingelheim and first launched in the United States under the name Micardis in 1999. In the same year, in Germany, it was launched by Boehringer Ingelheim and Glaxo Wellcome under the trade names of Micardis and Pritor respectively. Then it was marketed in several countries. The telmisartan patent expired in 2014.

At the end of 2000, Boehringer Ingelheim introduced the active pharmaceutical ingredient and preparations of Telmisartan in China. Telmisartan has grown rapidly since it entered China. Sales value continued to increase before 2014 when it started to decline, reaching around CNY 165 million in 2017. At present, the Chinese telmisartan market is dominated by Boehringer Ingelheim, China Resources Double -Crane Pharmaceutical Co., Ltd., Yichang HEC Changjiang Pharmaceutical Co., Ltd. and Jiangsu Wanbang Biopharmaceuticals Co., Ltd. Boehringer Ingelheim has the largest market share. In 2017, its market share in terms of sales was around 72.4% but showed a declining trend. With the growing number of hypertensive patients, the Chinese telmisartan market is expected to still have some growth potential.

Topics covered:

– Sales of Telmisartan in China

– Sales of Telmisartan in China by region

– Competitive landscape of the Chinese Telmisartan market

– Price of Telmisartan in China

– Main factors affecting the Chinese telmisartan market

– Perspective of the Chinese Telmisartan market

Inquire Before Purchasing This Report – https://www.marketreportsworld.com/enquiry/pre-order-enquiry/12855104

The China Telmisartan Market report provides an overview of key market drivers, challenges, opportunities and risks and vendor strategies. The major players are also presented with their market shares in the global telmisartan market in China. Overall, this report covers the historical situation, current state and future prospects. Moreover, the global market is segmented on the basis of type, application, offerings, and region. It contains numbers, regions, revenue and offers just like the in-depth calculation of business chain structure, opportunities and industry news analysis. The application part shows the uses of the product.

The China Telmisartan market report also covers a detailed understanding of the major geographies present in the market along with key segments and sub-segments. The report focuses on the state of regional development, which includes market size, share and volume.

Purchase this report (price 2200 USD for a single user license) – https://www.marketreportsworld.com/purchase/12855104

Detailed Table of Contents of Global Synthesis Gas Market Research Report

Contents
1 Relevant concepts of telmisartan
1.1 Indications for telmisartan
1.2 Development of Telmisartan in China
1.3 Government approval of telmisartan in China

2 Telmisartan sales in China, 2013-2017
2.1 Sales value of telmisartan
2.1.1 Overall value of sales
2.1.2 Sales value by region
2.2 Telmisartan sales volume
2. 2.1 Global sales volume
2.2.2 Sales Volume by Region
2.3 China Telmisartan Sales by Dosage Form, 2013-2017
2.3.1 Tablets
2.3.2 Capsules

3 China Telmisartan Major Manufacturers Analysis, 2013-2017
3.1 Major Manufacturers of Telmisartan Market Share Analysis
3.1.1 Market share by sales value
3.1.2 Market share by sales volume
3.2 Boehringer Ingelheim
3.2.1 Company profile
3.2.2 Sales of Boehringer Ingelheim Telmisartan in China
3.3 Chinese Resources Double-Crane Pharmaceutical Co., Ltd.
3.3.1 Company profile
3.3.2 China Resources Telmisartan sales of Double-Crane Pharmaceutical Co., Ltd. in China
3.4 Yichang HEC Changjiang Pharmaceutical Co., Ltd.
3.4.1 Company profile
3.4.2 Sales of Telmisartan from Yichang HEC Changjiang Pharmaceutical Co., Ltd. in China
3.5 Jiangsu Wanbang Biopharmaceuticals Co., Ltd.
3.5.1 Company Profile
3.5.2 Sales of Telmisartan from Jiangsu Wanbang Biopharmaceuticals Co., Ltd. in China
3.6 Suzhou Dawnrays Pharmaceutical Co., Ltd.
3.6.1 Company Profile
3.6.2 Sales of Telmisartan from Suzhou Dawnrays Pharmaceutical Co., Ltd. in China

4 Telmisartan price in China, 2017-2018
4.1 Boehringer Ingelheim (Micardis)
4.2 Chinese Resources Double-Crane Pharmaceutical Co., Ltd. (Suhe)
4.3 Yichang HEC Changjiang Pharmaceutical Co., Ltd. (Oumeining)
4.4 Jiangsu Wanbang Biopharmaceuticals Co., Ltd. (Bangtan)
4.5 Suzhou Dawnrays Pharmaceutical Co., Ltd. (Anneiqiang)

5 China Telmisartan Market Outlook, 2018-2022
5.1 Market Size Forecast
5.2 Market Trend Forecast

Browse the full table of contents at – https://www.marketreportsworld.com/TOC/12855104

About Us: –

World Market Reports is the credible source for getting the market reports that will give you the lead your business needs. The market is changing rapidly with the continued expansion of the industry. The advancement of technology has provided today’s businesses with multifaceted benefits resulting in daily economic changes. Thus, it is very important for a company to understand the patterns of market movements in order to better develop a strategy. An effective strategy gives businesses a head start in planning and an edge over the competition.

CONTACT US

Name: Ajay Plus

E-mail: [email protected]

Call: United States + (1) 424 253 0807 / United Kingdom + (44) 203 239 8187

Other reports here:

Surfactants Market Size, Share, Growth 2022 Global key findings, industry demand, regional analysis, key player profiles, future outlook and forecast till 2030

Surfactants Market Size, Share, Growth 2022 Global key findings, industry demand, regional analysis, key player profiles, future outlook and forecast till 2030

Surfactants Market Size, Share, Growth 2022 Global key findings, industry demand, regional analysis, key player profiles, future outlook and forecast till 2030

Surfactants Market Size, Share, Growth 2022 Global key findings, industry demand, regional analysis, key player profiles, future outlook and forecast till 2030

Surfactants Market Size, Share, Growth 2022 Global key findings, industry demand, regional analysis, key player profiles, future outlook and forecast till 2030

Global Five String Banjos Market industry growth analysis, segmentation, size, growth, share, trend, future demand, and major player updates by forecast to 2026

Global Five String Banjos Market industry growth analysis, segmentation, size, growth, share, trend, future demand, and major player updates by forecast to 2026

Global Five String Banjos Market industry growth analysis, segmentation, size, growth, share, trend, future demand, and major player updates by forecast to 2026

Global Five String Banjos Market industry growth analysis, segmentation, size, growth, share, trend, future demand, and major player updates by forecast to 2026

Global Five String Banjos Market industry growth analysis, segmentation, size, growth, share, trend, future demand, and major player updates by forecast to 2026

Share.

Comments are closed.